MALIGNANT MIXED MULLERIAN TUMOR VERSUS HIGH-GRADE ENDOMETRIAL CARCINOMA AND AGGRESSIVE VARIANTS OF ENDOMETRIAL CARCINOMA - A COMPARATIVE-ANALYSIS OF SURVIVAL
E. George et al., MALIGNANT MIXED MULLERIAN TUMOR VERSUS HIGH-GRADE ENDOMETRIAL CARCINOMA AND AGGRESSIVE VARIANTS OF ENDOMETRIAL CARCINOMA - A COMPARATIVE-ANALYSIS OF SURVIVAL, International journal of gynecological pathology, 14(1), 1995, pp. 39-44
To ascertain whether uterine malignant mixed mullerian tumors are biol
ogically distinct from high-grade endometrial carcinomas (FIGO grade 3
), we compared patient survival in 32 and 39 cases, respectively. The
Cox proportional hazard model was employed to determine whether tumor
type was an independent predictor of survival. The survival of patient
s with MMMT was also compared to that of patients with serous adenocar
cinoma and clear cell carcinoma. The 5-year overall and disease-free s
urvival were significantly lower for malignant mixed mullerian tumors
(25% and 11%) than for high-grade endometrial carcinomas (64% and 56%)
. Using the Cox proportional hazard model, tumor type (MMMT vs. high-g
rade endometrial carcinoma) was a statistically significant predictor
of survival after other important prognostic variables such as patholo
gic stage, depth of myometrial invasion, and vascular invasion had bee
n taken into account. The increased aggressiveness of MMMT appears mos
t attributable to their tendency to reach a more advanced stage by the
time of clinical presentation and to their greater propensity for upp
er abdominal dissemination. The survival of patients with MMMT was als
o lower than that of patients with the special histologic variants of
endometrial carcinoma, serous adenocarcinoma and clear cell carcinoma,
which are recognized for their unusually aggressive clinical behavior
. These results indicate that uterine malignant mixed mullerian tumors
are clinically more aggressive than high-grade endometrial carcinomas
and should continue to be recognized as a distinct entity.